- Home
- PAYO vs ARWR Comparison
PAYO vs ARWR Comparison
Compare PAYO & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYO
- ARWR
- Stock Information
- Founded
- PAYO 2005
- ARWR 2003
- Country
- PAYO United States
- ARWR United States
- Employees
- PAYO N/A
- ARWR N/A
- Industry
- PAYO EDP Services
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- PAYO Technology
- ARWR Health Care
- Exchange
- PAYO Nasdaq
- ARWR Nasdaq
- Market Cap
- PAYO 2.7B
- ARWR 2.5B
- IPO Year
- PAYO N/A
- ARWR 1993
- Fundamental
- Price
- PAYO $6.69
- ARWR $18.78
- Analyst Decision
- PAYO Strong Buy
- ARWR Buy
- Analyst Count
- PAYO 8
- ARWR 8
- Target Price
- PAYO $10.06
- ARWR $43.14
- AVG Volume (30 Days)
- PAYO 3.6M
- ARWR 2.3M
- Earning Date
- PAYO 08-06-2025
- ARWR 08-07-2025
- Dividend Yield
- PAYO N/A
- ARWR N/A
- EPS Growth
- PAYO N/A
- ARWR N/A
- EPS
- PAYO 0.25
- ARWR N/A
- Revenue
- PAYO $1,017,244,000.00
- ARWR $572,976,000.00
- Revenue This Year
- PAYO $4.94
- ARWR $22,384.93
- Revenue Next Year
- PAYO $5.85
- ARWR N/A
- P/E Ratio
- PAYO $26.64
- ARWR N/A
- Revenue Growth
- PAYO 13.02
- ARWR 2816.20
- 52 Week Low
- PAYO $5.71
- ARWR $9.57
- 52 Week High
- PAYO $11.29
- ARWR $27.34
- Technical
- Relative Strength Index (RSI)
- PAYO 48.87
- ARWR 61.33
- Support Level
- PAYO $6.59
- ARWR $15.01
- Resistance Level
- PAYO $6.90
- ARWR $20.00
- Average True Range (ATR)
- PAYO 0.26
- ARWR 0.91
- MACD
- PAYO 0.01
- ARWR 0.34
- Stochastic Oscillator
- PAYO 32.99
- ARWR 75.55
About PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.